About the journal
Eye is a journal published by Springer Nature in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,990 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Nature
- ISSN
- 1476-5454 · 0950-222X
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared publication charge
- 4,990 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.nature.com/eye/
Index listings
- MEDLINE · 1987-01-01
- PUBMED · 2008-02-15
- Indexing
- MEDLINE · PUBMED
- APC
- 4,990 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 84 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
13361
Last recorded publication year
2026
h-index
168
i10-index
6597
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 83%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 8703986
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Retinal Diseases and Treatments
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Glaucoma and retinal disorders
- Intraocular Surgery and Lenses
- Intraocular Surgery and Lenses
- Retinal and Macular Surgery
- Retinal and Macular Surgery
Show all subjects (50)
- Ophthalmology and Visual Impairment Studies
- Ophthalmology and Visual Impairment Studies
- Corneal surgery and disorders
- Corneal surgery and disorders
- Ocular Diseases and Behçet’s Syndrome
- Ocular Diseases and Behçet’s Syndrome
- Legal and Regulatory Analysis
- Linguistic, Cultural, and Literary Studies
- Military Technology and Strategies
- Linguistic, Cultural, and Literary Studies
- Legal and Regulatory Analysis
- Military Technology and Strategies
- Retinal and Optic Conditions
- Retinal and Optic Conditions
- Retinal Imaging and Analysis
- Retinal Imaging and Analysis
- Ocular Infections and Treatments
- Ocular Surface and Contact Lens
- Ocular Surface and Contact Lens
- Ocular Infections and Treatments
- Corneal Surgery and Treatments
- Corneal Surgery and Treatments
- Ocular Oncology and Treatments
- Ocular Oncology and Treatments
- Ophthalmology and Eye Disorders
- Ophthalmology and Eye Disorders
- Retinal Development and Disorders
- Retinal Development and Disorders
- Retinopathy of Prematurity Studies
- Retinopathy of Prematurity Studies
- Ocular Disorders and Treatments
- Ocular Disorders and Treatments
- Traumatic Ocular and Foreign Body Injuries
- Traumatic Ocular and Foreign Body Injuries
- Cerebral Venous Sinus Thrombosis
- Cerebral Venous Sinus Thrombosis
- Ophthalmology and Visual Health Research
- Ophthalmology and Visual Health Research
- Drug-Induced Ocular Toxicity
- Drug-Induced Ocular Toxicity
- Nasolacrimal Duct Obstruction Treatments
- Nasolacrimal Duct Obstruction Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ